Djura Piersma - Concepedia

Author

Djura Piersma

University Medical Center Groningen ORCID

Also Known As

Carola Pierobon, D Piersma, D. Piersma, Djura P. Piersma, Djura P. Piersma, Djura Piersma, Jose Angel Arranz, Maria de Piero, Piersma D.

165

Publications

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen Medisch Spectrum Twente University Medical Center Utrecht Radboud University Medical Center Radboud University Nijmegen

About

Djura Piersma is an author at University Medical Center Groningen specializing in medicine, oncology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	369
2	Health Policy	2	2	113
3	Health Sciences	1	1	10
4	Cell Biology	1	1	20
5	Endocrinology	1	1	45

Djura Piersma

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, New England Journal of Medicine	2022	474
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome Olivier Valkenburg, André G. Uitterlinden, Djura Piersma, Human Reproduction	2009	126
Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands Anouk Jochems, Maartje G. Schouwenburg, B Leeneman, European Journal of Cancer Quality AssuranceOncologySurgical OncologyHealth PolicyPatient Safety	2016	103
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease Monique K. van der Kooij, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Annals of Internal Medicine	2021	103
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma Olivier J. van Not, Rik J. Verheijden, Alfonsus Johannes Maria van den Eertwegh, JAMA Oncology	2022	99
A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients Djura Piersma, Els M.J.J. Berns, Miriam Verhoef‐Post, The Journal of Clinical Endocrinology & Metabolism	2006	60
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study Olivier J. van Not, Melissa M. de Meza, Alfons J.M. van den Eertwegh, European Journal of Cancer	2022	56
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset Brenda L. Powell, Djura Piersma, Marlies E. Kevenaar, The Journal of Clinical Endocrinology & Metabolism	2003	49
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial Evalyn E.A.P. Mulder, Karlijn de Joode, Saskia Litière, BMC Cancer	2021	49
Polymorphic variations in exon 10 of the luteinizing hormone receptor: Functional consequences and associations with breast cancer Djura Piersma, Miriam Verhoef‐Post, Maxime P. Look, Molecular and Cellular Endocrinology Breast OncologySignal TransductionHormonal ReceptorGeneticsHormone Receptor	2007	45

Page 1